 NEW YORK, June 4, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Constellation Pharmaceuticals, Inc. CNST or the Company CNST relating to its proposed acquisition by MorphoSys AG MOR. Under the terms of the agreement, CNST shareholders will receive 34.00 in cash per share they own. 